Resultados de la búsqueda 281-290 of 6283 for Receptor

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

2. Neurología - Ensayos clínicos - Mayo Clinic

   ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

3. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

   This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor ... The second aim of this study is to sequence the TCR receptors of ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

6. Neurología - Ensayos clínicos - Mayo Clinic

   ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... receptor positive bronchial neuroendocrine tumors that have spread to other places in the body (advanced). Radioactive drugs, such as lutetium Lu 177 ...

8. linfoma linfocítico de células pequeñas - Diagnósticos y tratamientos - Mayo Clinic

   Otras opciones de tratamiento pueden incluir el trasplante de médula ósea, o trasplante de células madre de médula ósea, la terapia de células T con receptor de ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... receptor positive bronchial neuroendocrine tumors that have spread to other places in the body (advanced). Radioactive drugs, such as lutetium Lu 177 ...

10. Neurología - Ensayos clínicos - Mayo Clinic

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...